Back to SC US (TTGP), Ltd. SC US (TTGP), Ltd.

BBIOBBIO

Showing 8 of 29 quarters

Position history for SC US (TTGP), Ltd.SC US (TTGP), Ltd.'s holdings in BridgeBio Pharma, Inc.

Yes. SC US (TTGP) holds 1,860,364 shares of BBIO (BridgeBio Pharma), worth $138.6M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. SC US (TTGP) has held BBIO since Q2 2019, across 29 quarterly 13F filings. BBIO is 0.4% of SC US (TTGP)'s reported 13F portfolio.

Current Value

$138.6M

Current Shares

1.9M

Total Value Change

+$91.2M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
1.9M
0.0%
$138.6M0.4%$74.48
0
2026-Q1
Unchanged
1.9M
0.0%
$138.2M1.5%$74.26
0
2025-Q4
Unchanged
1.9M
0.0%
$142.3M1.0%$76.49
0
2025-Q3
Unchanged
1.9M
0.0%
$96.6M0.6%$51.94
0
2025-Q2
Unchanged
1.9M
0.0%
$80.3M0.6%$43.18
0
2025-Q1
Unchanged
1.9M
0.0%
$64.3M0.6%$34.57
0
2024-Q4
Unchanged
1.9M
0.0%
$51M0.4%$27.44
0
2024-Q3
Unchanged
1.9M
0.0%
$47.4M0.3%$25.46
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used